This is a type of radioactive sugar used in medical scans. It's injected into your body, and a special camera detects the radiation. Doctors use it to look at how well your brain and heart are using sugar, which helps diagnose conditions like stroke or heart problems.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Fluorodeoxyglucose F18, usually called FDG (and labeled in the US as fludeoxyglucose F 18 injection), is a radioactive tracer used for positron emission tomography, or PET, scans. It is not a treatment. It is a diagnostic drug that lets a scanner show which tissues in the body are using sugar most actively, which helps doctors find and understand disease. It has three FDA-approved uses. In cancer care, an FDG PET scan helps evaluate a suspicious finding seen on another test and is widely used in people already diagnosed with cancer to see where the disease is and how it is responding to treatment. In heart disease, it is used alongside a separate blood-flow scan to show whether weakened heart muscle in people with coronary artery disease is still alive and might recover if blood flow is restored with a stent or bypass surgery. In epilepsy, it helps locate the area of the brain where seizures start, which matters when surgery is being considered. FDG is made by many local radiopharmacies and has no familiar consumer brand name.
FDG is a modified form of glucose, the sugar cells use for energy, with a radioactive fluorine atom attached. After it is injected into a vein, cells take it up as if it were ordinary glucose. Unlike glucose, though, it cannot be fully broken down, so it becomes trapped inside the cells that absorbed it. Tissues that burn a lot of sugar, such as many cancers, therefore collect more FDG than their surroundings and show up as bright areas on the PET images, while tissue using less sugar appears dimmer. In the heart, muscle that is short of blood but still alive switches toward using glucose, so it takes up FDG even where blood flow is reduced. In epilepsy, the brain area where seizures start often uses less sugar than normal between seizures and appears as a dimmer region. The radioactive fluorine loses half of its radioactivity about every 110 minutes, so the tracer fades quickly, and most of it leaves the body in urine within a day.
FDG is given once, as a small injection into a vein at the imaging center, by staff trained to handle radioactive drugs. The dose is measured in advance for each scan, and for adults it falls in a standard range for all three uses. Children may receive it for epilepsy imaging at a smaller dose. Preparation affects how useful the images are. For cancer and brain scans, people are usually asked not to eat for 4 to 6 hours beforehand, while drinking plain water is encouraged. Heart scans are different: a measured amount of sugar is often given before the injection, because it helps heart muscle take up the tracer. Imaging guidelines also advise avoiding strenuous exercise for at least 6 hours, and ideally the day before, because working muscles absorb FDG and can blur the results. Blood sugar is usually checked before the injection. High sugar levels compete with FDG and can make cancer and brain images less reliable, and a scan may be rescheduled if the level is well above normal (one widely used guideline uses about 200 mg/dL as the cutoff). People with diabetes, especially those using insulin, should ask the imaging center for specific instructions on eating and medicine timing rather than skipping doses on their own. After the scan, drinking fluids and urinating often for the next hour or so helps clear the tracer and lowers the radiation dose to the bladder.
Most people feel nothing from FDG itself. The amount injected is tiny, it does not act as a sedative, and it does not change how a person thinks or feels. Any tiredness or hunger afterward is usually from fasting and lying still rather than from the tracer. Allergic-type reactions with itching, swelling or rash have been reported but are uncommon. Because they would typically begin while you are still at the imaging center, staff there are equipped to respond, so tell them right away if you notice any of these.
FDG has no listed contraindications, meaning there is no medical condition that automatically rules it out. Formal drug interaction studies have not been done; in practice, the main concern is anything that raises blood sugar or changes how muscles and other tissues take up glucose, which can affect image quality. Tell the imaging team about diabetes medicines and any recent illness or infection. The scan involves radiation, which may slightly raise lifetime cancer risk, a concern that matters more for children because their tissues are more sensitive. For that reason the smallest effective dose is used, and the decision to scan weighs this against the value of the information. Tell the team if you are pregnant or might be. FDG crosses the placenta, and although published reports in pregnancy have not shown a link to birth defects or miscarriage, any radiation to a developing baby is taken seriously and the timing and need for the scan should be discussed. If you are breastfeeding, the US label advises pumping and discarding breast milk and avoiding close contact with the baby for at least 9 hours after the injection. Some imaging centers recommend longer limits on close contact, so follow your center's specific instructions.
After the injection, you usually rest quietly in a reclining chair or bed for about 30 to 60 minutes while the tracer spreads through the body. Staying still, warm and silent during this time matters, because talking, chewing, moving or shivering can make muscles or fat take up the tracer and confuse the images. The scan itself usually takes about 20 to 45 minutes lying still on a table, and it is often combined with a computed tomography (CT) scan in the same machine, which adds detailed anatomy to the activity map. Most people can go back to their normal activities right away, and the radioactivity fades within hours. A nuclear medicine physician or radiologist reads the images and sends a report to the doctor who ordered the scan. FDG PET is powerful but not definitive. Infection, inflammation and some benign growths can also light up, and some cancers take up little FDG, so a normal scan does not completely rule out cancer and a bright spot does not prove it. Findings are interpreted together with other imaging, symptoms and, when needed, a biopsy. People with cancer may have repeat scans to track how treatment is working.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Fluorodeoxyglucose F18, what you've noticed, or ask the community a question.